Product analysis: upon receipt at medtronic¿s quality laboratory, the valve inflow struts were flared out and a piece of pannus was found attached on the outside of the inflow struts.Calcification was noted on the pannus, found attached on the outside of the inflow struts.Radiography confirmed extensive calcification on the attached pannus.Pannus was also observed on the top of the inflow and the outflow crown.The leaflets were thickened, but were flexible and intact.The leaflets were open against the inner lumen and no visible pannus or calcification was noted on the leaflets.The commissures of the valve were found to be intact.Radiography could not confirm calcification on the valve.Conclusion: calcification and pannus have been an inherent risk of cardiac surgeries.Due to the fact that a great proportion of congenital heart valve abnormalities present as emergent cases in neonates, infants and young children, the patient¿s physical growth is an unavoidable event; and eventually a reoperation and replacement of the device may be required.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.
|
Medtronic received information that three years following the implant of this transcatheter pulmonary bioprosthetic valve (tpbv), echocardiogram showed a gradient of 40 mmhg across the valve.The valve was removed due to stenosis and surgically replaced with a bioprosthetic valve.During the valve replacement procedure, severe calcification was identified in the right ventricular outflow tract.Per the physician, the valve was severely stenotic secondary to dysplastic and fibrotic leaflets within the valve.The physician noted that an element of outgrowth was a factor in the performance of the valve, but stated that the leaflet degeneration was the primary cause of the stenosis of the valve.No other adverse patient effects were reported.
|